| Product Code: ETC11977711 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
The import shipments of dendritic cell cancer vaccines to Israel in 2024 continued to predominantly come from top exporting countries such as Switzerland, USA, Germany, China, and Belgium. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the negative compound annual growth rate (CAGR) from 2020-24 suggests a decline in demand. However, the positive growth rate from 2023-24 of 8.63% signals a potential turnaround in the market dynamics. Israel`s reliance on key exporting countries underscores the importance of maintaining strong trade relations for a steady supply of cancer vaccines.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Dendritic Cell Cancer Vaccines Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Dendritic Cell Cancer Vaccines Market - Industry Life Cycle |
3.4 Israel Dendritic Cell Cancer Vaccines Market - Porter's Five Forces |
3.5 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.6 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.7 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
4 Israel Dendritic Cell Cancer Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Dendritic Cell Cancer Vaccines Market Trends |
6 Israel Dendritic Cell Cancer Vaccines Market, By Types |
6.1 Israel Dendritic Cell Cancer Vaccines Market, By Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Cancer Type, 2021 - 2031F |
6.1.3 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Lung, 2021 - 2031F |
6.1.4 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Breast, 2021 - 2031F |
6.1.5 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2 Israel Dendritic Cell Cancer Vaccines Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3 Israel Dendritic Cell Cancer Vaccines Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Online, 2021 - 2031F |
6.4 Israel Dendritic Cell Cancer Vaccines Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.3 Israel Dendritic Cell Cancer Vaccines Market Revenues & Volume, By Intravenous, 2021 - 2031F |
7 Israel Dendritic Cell Cancer Vaccines Market Import-Export Trade Statistics |
7.1 Israel Dendritic Cell Cancer Vaccines Market Export to Major Countries |
7.2 Israel Dendritic Cell Cancer Vaccines Market Imports from Major Countries |
8 Israel Dendritic Cell Cancer Vaccines Market Key Performance Indicators |
9 Israel Dendritic Cell Cancer Vaccines Market - Opportunity Assessment |
9.1 Israel Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.2 Israel Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By End User, 2021 & 2031F |
9.3 Israel Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Israel Dendritic Cell Cancer Vaccines Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
10 Israel Dendritic Cell Cancer Vaccines Market - Competitive Landscape |
10.1 Israel Dendritic Cell Cancer Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Israel Dendritic Cell Cancer Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |